公开(公告)号：US20240109886A1

公开(公告)日：2024-04-04

申请号：US18263481

申请日：2022-01-28

Applicant: GRIFFITH UNIVERSITY

Inventor： Mark VON ITZSTEIN ,  Ibrahim EL-DEEB ,  Patrice GUILLON ,  Larissa HEILIG

IPC: C07D471/04 ,  A61P31/16 ,  C07D487/04 ,  C07D495/04

CPC classification number: C07D471/04 ,  A61P31/16 ,  C07D487/04 ,  C07D495/04

Abstract: The present invention relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and to pharmaceutical compositions comprising the compound. In Formula (I), rings W, X, Y and Z may relate to various heterocyclic, heteroaryl, cycloalkyl, cycloalkenyl, and/or aryl rings. The present invention also relates to uses of the compounds in treating a disease, disorder or condition caused by viral infection. (I) R3 is selected from the group consisting of: